{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:17:31Z","timestamp":1786465051199,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB216109"],"award-info":[{"award-number":["20232BAB216109"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05238-z","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:45:17Z","timestamp":1780728317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Yajie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"1","key":"5238_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"5238_CR2","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1038\/s41388-020-1234-3","volume":"39","author":"MM Wolf","year":"2020","unstructured":"Wolf MM, Kimryn Rathmell W, Beckermann KE. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene. 2020;39(17):3413\u201326. https:\/\/doi.org\/10.1038\/s41388-020-1234-3.","journal-title":"Oncogene"},{"issue":"1","key":"5238_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","volume":"22","author":"RJ Motzer","year":"2024","unstructured":"Motzer RJ, Jonasch E, Agarwal N, et al. NCCN Guidelines\u00ae Insights: Kidney Cancer, Version 2.2024. J Natl Compr Canc Netw. 2024;22(1):4\u201316. https:\/\/doi.org\/10.6004\/jnccn.2024.0008.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"5238_CR4","doi-asserted-by":"publisher","first-page":"189240","DOI":"10.1016\/j.bbcan.2024.189240","volume":"1880","author":"L Rinaldi","year":"2025","unstructured":"Rinaldi L, Senatore E, Feliciello S, Chiuso F, Insabato L, Feliciello A. Kidney cancer: From tumor biology to innovative therapeutics. Biochim Biophys Acta Rev Cancer. 2025;1880(1):189240. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189240.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5238_CR5","doi-asserted-by":"publisher","first-page":"154837","DOI":"10.1016\/j.metabol.2021.154837","volume":"123","author":"GS Jensen","year":"2021","unstructured":"Jensen GS, Leon-Palmer NE, Townsend KL. Bone morphogenetic proteins (BMPs) in the central regulation of energy balance and adult neural plasticity. Metabolism. 2021;123:154837. https:\/\/doi.org\/10.1016\/j.metabol.2021.154837.","journal-title":"Metabolism"},{"issue":"1","key":"5238_CR6","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41467-025-57185-y","volume":"16","author":"M Pan","year":"2025","unstructured":"Pan M, Zhang Y, Wright WC, et al. Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid. Nat Commun. 2025;16(1):2036. https:\/\/doi.org\/10.1038\/s41467-025-57185-y.","journal-title":"Nat Commun"},{"key":"5238_CR7","doi-asserted-by":"publisher","unstructured":"Guo CH, Wang QQ, Li JQ, et al. BMP1 inhibitor UK383367 improves MI-induced cardiac remodeling and fibrosis in mice via ameliorating macrophage polarization and mitochondrial dysfunction. Acta Pharmacol Sin Published online September. 2025;2. https:\/\/doi.org\/10.1038\/s41401-025-01655-y.","DOI":"10.1038\/s41401-025-01655-y"},{"issue":"1","key":"5238_CR8","doi-asserted-by":"publisher","first-page":"18813","DOI":"10.1038\/s41598-022-22879-6","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao J, Zou J, Jiao W, Lin L, Wang J, Lin Z. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis. Sci Rep. 2022;12(1):18813. https:\/\/doi.org\/10.1038\/s41598-022-22879-6.","journal-title":"Sci Rep"},{"issue":"1","key":"5238_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1186\/s12885-021-08611-z","volume":"21","author":"J Li","year":"2021","unstructured":"Li J, Cao J, Li P, et al. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. BMC Cancer. 2021;21(1):858. https:\/\/doi.org\/10.1186\/s12885-021-08611-z.","journal-title":"BMC Cancer"},{"issue":"6","key":"5238_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"key":"5238_CR11","doi-asserted-by":"publisher","first-page":"118030","DOI":"10.1016\/j.ecoenv.2025.118030","volume":"293","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang J, Fu Q, Zhao H, Wang Z, Gao Y. Efficient evaluation of osteotoxicity and mechanisms of endocrine disrupting chemicals using network toxicology and molecular docking approaches: triclosan as a model compound. Ecotoxicol Environ Saf. 2025;293:118030. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.118030.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"5238_CR12","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1186\/s12967-025-07253-0","volume":"23","author":"T Yu","year":"2025","unstructured":"Yu T, Fang Z, Cheng Y, Zhou Y, Ji Y, Liu C. A novel palmitoylation-based molecular signature reveals COX6A1 as a key regulator in metabolic dysfunction-associated steatotic liver disease. J Transl Med. 2025;23(1):1212. https:\/\/doi.org\/10.1186\/s12967-025-07253-0.","journal-title":"J Transl Med"},{"issue":"3","key":"5238_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringn\u00e9r","year":"2008","unstructured":"Ringn\u00e9r M. What is principal component analysis? Nat Biotechnol. 2008;26(3):303\u20134. https:\/\/doi.org\/10.1038\/nbt0308-303.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"5238_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370. https:\/\/doi.org\/10.1200\/JCO.2007.12.9791.","journal-title":"J Clin Oncol"},{"issue":"43","key":"5238_CR15","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"5238_CR16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"issue":"W1","key":"5238_CR17","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"5238_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"6","key":"5238_CR19","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"3","key":"5238_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/nprot.2006.236","volume":"1","author":"T Nolan","year":"2006","unstructured":"Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3):1559\u201382. https:\/\/doi.org\/10.1038\/nprot.2006.236.","journal-title":"Nat Protoc"},{"issue":"1","key":"5238_CR21","doi-asserted-by":"publisher","first-page":"20266","DOI":"10.1038\/s41598-023-46577-z","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang M, Song L, et al. Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma. Sci Rep. 2023;13(1):20266. https:\/\/doi.org\/10.1038\/s41598-023-46577-z.","journal-title":"Sci Rep"},{"issue":"1","key":"5238_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu MY, Luo LS, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64. https:\/\/doi.org\/10.1186\/s40779-024-00569-w.","journal-title":"Mil Med Res"},{"issue":"12","key":"5238_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal Cell Carcinoma: A Review. JAMA. 2024;332(12):1001\u201310. https:\/\/doi.org\/10.1001\/jama.2024.12848.","journal-title":"JAMA"},{"issue":"8","key":"5238_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.urolonc.2025.02.016","volume":"43","author":"G Lucarelli","year":"2025","unstructured":"Lucarelli G, Lasorsa F, Milella M, et al. Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma. Urol Oncol. 2025;43(8):469. e19-469.e32.","journal-title":"Urol Oncol"},{"issue":"4","key":"5238_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14737159.2023.2195553","volume":"23","author":"NA di Meo","year":"2023","unstructured":"di Meo NA, Lasorsa F, Rutigliano M, et al. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery. Expert Rev Mol Diagn. 2023;23(4):297\u2013313. https:\/\/doi.org\/10.1080\/14737159.2023.2195553.","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"5238_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli G, Loizzo D, Franzin R, et al. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma. Expert Rev Mol Diagn. 2019;19(5):397\u2013407. https:\/\/doi.org\/10.1080\/14737159.2019.1607729.","journal-title":"Expert Rev Mol Diagn"},{"issue":"22","key":"5238_CR27","doi-asserted-by":"publisher","first-page":"14360","DOI":"10.3390\/ijms232214360","volume":"23","author":"NA di Meo","year":"2022","unstructured":"di Meo NA, Lasorsa F, Rutigliano M, et al. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. Int J Mol Sci. 2022;23(22):14360. https:\/\/doi.org\/10.3390\/ijms232214360.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5238_CR28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/1873-3468.14531","volume":"597","author":"S De Marco","year":"2023","unstructured":"De Marco S, Torsello B, Minutiello E, et al. The cross-talk between Abl2 tyrosine kinase and TGF\u03b21 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells. FEBS Lett. 2023;597(8):1098\u2013113. https:\/\/doi.org\/10.1002\/1873-3468.14531.","journal-title":"FEBS Lett"},{"issue":"12","key":"5238_CR29","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.18632\/aging.101685","volume":"10","author":"G Lucarelli","year":"2018","unstructured":"Lucarelli G, Rutigliano M, Sallustio F, et al. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma. Aging. 2018;10(12):3957\u201385. https:\/\/doi.org\/10.18632\/aging.101685.","journal-title":"Aging"},{"issue":"69","key":"5238_CR30","doi-asserted-by":"publisher","first-page":"113502","DOI":"10.18632\/oncotarget.23056","volume":"8","author":"C Bianchi","year":"2017","unstructured":"Bianchi C, Meregalli C, Bombelli S, et al. The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation. Oncotarget. 2017;8(69):113502\u201315. https:\/\/doi.org\/10.18632\/oncotarget.23056.","journal-title":"Oncotarget"},{"issue":"1","key":"5238_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/diseases4010007","volume":"4","author":"R Ragone","year":"2016","unstructured":"Ragone R, Sallustio F, Piccinonna S, et al. Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics. Diseases. 2016;4(1):7. https:\/\/doi.org\/10.3390\/diseases4010007.","journal-title":"Diseases"},{"issue":"15","key":"5238_CR32","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.18632\/oncotarget.3823","volume":"6","author":"G Lucarelli","year":"2015","unstructured":"Lucarelli G, Galleggiante V, Rutigliano M, et al. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. Oncotarget. 2015;6(15):13371\u201386. https:\/\/doi.org\/10.18632\/oncotarget.3823.","journal-title":"Oncotarget"},{"issue":"1","key":"5238_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10238-026-02042-5","volume":"26","author":"G Lucarelli","year":"2026","unstructured":"Lucarelli G, Lasorsa F, Milella M, et al. MUC1\/CA15-3 identifies a clear cell renal carcinoma characterized by Sunitinib response with a specific metabolic signature. Clin Exp Med. 2026;26(1):106. https:\/\/doi.org\/10.1007\/s10238-026-02042-5.","journal-title":"Clin Exp Med"},{"issue":"22","key":"5238_CR34","doi-asserted-by":"publisher","first-page":"13968","DOI":"10.3390\/ijms232213968","volume":"23","author":"G Lucarelli","year":"2022","unstructured":"Lucarelli G, Rutigliano M, Loizzo D, et al. MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome. Int J Mol Sci. 2022;23(22):13968. https:\/\/doi.org\/10.3390\/ijms232213968.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"5238_CR35","doi-asserted-by":"publisher","first-page":"13179","DOI":"10.3390\/ijms241713179","volume":"24","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, et al. Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers. Int J Mol Sci. 2023;24(17):13179. https:\/\/doi.org\/10.3390\/ijms241713179.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5238_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/cells14100717","volume":"14","author":"M Milella","year":"2025","unstructured":"Milella M, Rutigliano M, Pandolfo SD, et al. The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy. Cells. 2025;14(10):717. https:\/\/doi.org\/10.3390\/cells14100717.","journal-title":"Cells"},{"issue":"4","key":"5238_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.eururo.2011.06.041","volume":"60","author":"M Sun","year":"2011","unstructured":"Sun M, Shariat SF, Cheng C, et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 2011;60(4):644\u201361. https:\/\/doi.org\/10.1016\/j.eururo.2011.06.041.","journal-title":"Eur Urol"},{"key":"5238_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2015.11.009","volume":"27","author":"H Davis","year":"2016","unstructured":"Davis H, Raja E, Miyazono K, Tsubakihara Y, Moustakas A. Mechanisms of action of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev. 2016;27:81\u201392. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.11.009.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"5238_CR39","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.gastro.2020.11.011","volume":"160","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi H, Gieniec KA, Wright JA, et al. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis. Gastroenterology. 2021;160(4):1224\u2013e123930. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.011.","journal-title":"Gastroenterology"},{"issue":"2","key":"5238_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/biom13020306","volume":"13","author":"S Yang","year":"2023","unstructured":"Yang S, Ji J, Wang M, Nie J, Wang S. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA. Biomolecules. 2023;13(2):306. https:\/\/doi.org\/10.3390\/biom13020306.","journal-title":"Biomolecules"},{"key":"5238_CR41","doi-asserted-by":"publisher","first-page":"719175","DOI":"10.3389\/fimmu.2021.719175","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu Z, Peng B, Liang Q, et al. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Front Immunol. 2021;12:719175. https:\/\/doi.org\/10.3389\/fimmu.2021.719175.","journal-title":"Front Immunol"},{"issue":"1","key":"5238_CR42","doi-asserted-by":"publisher","first-page":"2541316","DOI":"10.1080\/07853890.2025.2541316","volume":"57","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Ye R, Qian Y, et al. Machine learning and SHAP value interpretation for predicting the response to neoadjuvant chemotherapy and long-term clinical outcomes in Chinese female breast cancer. Ann Med. 2025;57(1):2541316. https:\/\/doi.org\/10.1080\/07853890.2025.2541316.","journal-title":"Ann Med"},{"issue":"3","key":"5238_CR43","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.acra.2025.10.050","volume":"33","author":"Q Yuan","year":"2026","unstructured":"Yuan Q, Hong Z, Ye R, et al. Integrating Deep Feature Extraction and MRI Radiomics for Survival Prediction in Breast Cancer After Neoadjuvant Chemotherapy. Acad Radiol. 2026;33(3):872\u201388. https:\/\/doi.org\/10.1016\/j.acra.2025.10.050.","journal-title":"Acad Radiol"},{"issue":"5\u20136","key":"5238_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10495-023-01932-3","volume":"29","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Wang J, Dao C, et al. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma. Apoptosis. 2024;29(5\u20136):681\u201392. https:\/\/doi.org\/10.1007\/s10495-023-01932-3.","journal-title":"Apoptosis"},{"key":"5238_CR45","doi-asserted-by":"publisher","first-page":"1038457","DOI":"10.3389\/fphar.2023.1038457","volume":"14","author":"SC Li","year":"2023","unstructured":"Li SC, Yan LJ, Wei XL, Jia ZK, Yang JJ, Ning XH. A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer. Front Pharmacol. 2023;14:1038457. https:\/\/doi.org\/10.3389\/fphar.2023.1038457.","journal-title":"Front Pharmacol"},{"issue":"11","key":"5238_CR46","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s43018-020-00130-3","volume":"1","author":"K Ganesh","year":"2020","unstructured":"Ganesh K, Basnet H, Kaygusuz Y, et al. Author Correction: L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. Nat Cancer. 2020;1(11):1128. https:\/\/doi.org\/10.1038\/s43018-020-00130-3.","journal-title":"Nat Cancer"},{"key":"5238_CR47","doi-asserted-by":"publisher","first-page":"1536478","DOI":"10.3389\/fphar.2024.1536478","volume":"15","author":"J Hu","year":"2025","unstructured":"Hu J, Cao J, Huang S, Chen Y. ITGAX promotes gastric cancer progression via epithelial-mesenchymal transition pathway. Front Pharmacol. 2025;15:1536478. https:\/\/doi.org\/10.3389\/fphar.2024.1536478.","journal-title":"Front Pharmacol"},{"issue":"9","key":"5238_CR48","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/life12091381","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Tang Y, Cai J, Wu S, Song F. MPP7 as a Novel Biomarker of Esophageal Cancer: MPP7 Knockdown Inhibits Esophageal Cancer Cell Migration and Invasion. Life (Basel). 2022;12(9):1381. https:\/\/doi.org\/10.3390\/life12091381.","journal-title":"Life (Basel)"},{"issue":"12","key":"5238_CR49","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1007\/s00432-023-04927-4","volume":"149","author":"Q Huang","year":"2023","unstructured":"Huang Q, Lv Q, Tang W, et al. A comprehensively prognostic and immunological analysis of chloride intracellular channel protein 5 (CLIC5) in pan-cancer and identification in ovarian cancer. J Cancer Res Clin Oncol. 2023;149(12):10561\u201383. https:\/\/doi.org\/10.1007\/s00432-023-04927-4.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5238_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13046-025-03312-y","volume":"44","author":"Q He","year":"2025","unstructured":"He Q, Hu J, Ngo FY, et al. Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization. J Exp Clin Cancer Res. 2025;44(1):55. https:\/\/doi.org\/10.1186\/s13046-025-03312-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5238_CR51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1186\/s12967-024-05858-5","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang X, Gao L, Li H, et al. Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinoma. J Transl Med. 2024;22(1):1104. https:\/\/doi.org\/10.1186\/s12967-024-05858-5.","journal-title":"J Transl Med"},{"key":"5238_CR52","doi-asserted-by":"publisher","first-page":"109578","DOI":"10.1016\/j.biopha.2019.109578","volume":"121","author":"HL Ma","year":"2020","unstructured":"Ma HL, Yu SJ, Chen J, et al. CA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue. Biomed Pharmacother. 2020;121:109578. https:\/\/doi.org\/10.1016\/j.biopha.2019.109578.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5238_CR53","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/s41467-021-21960-4","volume":"12","author":"S Coassolo","year":"2021","unstructured":"Coassolo S, Davidson G, Negroni L, et al. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation. Nat Commun. 2021;12(1):1718. https:\/\/doi.org\/10.1038\/s41467-021-21960-4.","journal-title":"Nat Commun"},{"issue":"4","key":"5238_CR54","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2353\/ajpath.2009.080879","volume":"174","author":"Z Chen","year":"2009","unstructured":"Chen Z, Qiu X, Gu J. Immunoglobulin expression in non-lymphoid lineage and neoplastic cells. Am J Pathol. 2009;174(4):1139\u201348. https:\/\/doi.org\/10.2353\/ajpath.2009.080879.","journal-title":"Am J Pathol"},{"issue":"5","key":"5238_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/cmi.2008.39","volume":"5","author":"D Hu","year":"2008","unstructured":"Hu D, Zheng H, Liu H, et al. Immunoglobulin expression and its biological significance in cancer cells. Cell Mol Immunol. 2008;5(5):319\u201324. https:\/\/doi.org\/10.1038\/cmi.2008.39.","journal-title":"Cell Mol Immunol"},{"issue":"21","key":"5238_CR56","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.3390\/ijms252111825","volume":"25","author":"H Yang","year":"2024","unstructured":"Yang H, Zhang Z, Li J, Wang K, Zhu W, Zeng Y. The Dual Role of B Cells in the Tumor Microenvironment: Implications for Cancer Immunology and Therapy. Int J Mol Sci. 2024;25(21):11825. https:\/\/doi.org\/10.3390\/ijms252111825.","journal-title":"Int J Mol Sci"},{"key":"5238_CR57","doi-asserted-by":"publisher","first-page":"611795","DOI":"10.3389\/fimmu.2021.611795","volume":"12","author":"D Catal\u00e1n","year":"2021","unstructured":"Catal\u00e1n D, Mansilla MA, Ferrier A, et al. Immunosuppressive Mechanisms of Regulatory B Cells. Front Immunol. 2021;12:611795. https:\/\/doi.org\/10.3389\/fimmu.2021.611795.","journal-title":"Front Immunol"},{"issue":"1","key":"5238_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13059-016-0995-z","volume":"17","author":"D Aran","year":"2016","unstructured":"Aran D, Lasry A, Zinger A, et al. Widespread parainflammation in human cancer. Genome Biol. 2016;17(1):145. https:\/\/doi.org\/10.1186\/s13059-016-0995-z.","journal-title":"Genome Biol"},{"key":"5238_CR59","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.ctrv.2020.102084","volume":"89","author":"MG McNamara","year":"2020","unstructured":"McNamara MG, Jacobs T, Lamarca A, Hubner RA, Valle JW, Amir E. Impact of high tumor mutational burden in solid tumors and challenges for biomarker application. Cancer Treat Rev. 2020;89:102084. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102084.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"5238_CR60","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ccell.2022.08.022","volume":"40","author":"AH Nassar","year":"2022","unstructured":"Nassar AH, Adib E, Abou Alaiwi S, et al. Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors. Cancer Cell. 2022;40(10):1161\u2013e11725. https:\/\/doi.org\/10.1016\/j.ccell.2022.08.022.","journal-title":"Cancer Cell"},{"issue":"10","key":"5238_CR61","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","volume":"9","author":"L Vuong","year":"2019","unstructured":"Vuong L, Kotecha RR, Voss MH, Hakimi AA. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma. Cancer Discov. 2019;9(10):1349\u201357. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0499.","journal-title":"Cancer Discov"},{"key":"5238_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12967-016-0841-9","volume":"14","author":"M Gigante","year":"2016","unstructured":"Gigante M, Pontrelli P, Herr W, et al. miR-29b and miR-198 overexpression in CD8\u2009+\u2009T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. J Transl Med. 2016;14:84. https:\/\/doi.org\/10.1186\/s12967-016-0841-9.","journal-title":"J Transl Med"},{"issue":"8","key":"5238_CR63","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.18632\/aging.103169","volume":"12","author":"GS Netti","year":"2020","unstructured":"Netti GS, Lucarelli G, Spadaccino F, et al. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma. Aging. 2020;12(8):7585\u2013602. https:\/\/doi.org\/10.18632\/aging.103169.","journal-title":"Aging"},{"issue":"7","key":"5238_CR64","doi-asserted-by":"publisher","first-page":"461e","DOI":"10.1016\/j.urolonc.2017.02.011","volume":"35","author":"G Lucarelli","year":"2017","unstructured":"Lucarelli G, Rutigliano M, Ferro M, et al. Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma. Urol Oncol. 2017;35(7):461e. 15-461.e27.","journal-title":"Urol Oncol"},{"issue":"22","key":"5238_CR65","doi-asserted-by":"publisher","first-page":"16515","DOI":"10.3390\/ijms242216515","volume":"24","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, et al. Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma. Int J Mol Sci. 2023;24(22):16515. https:\/\/doi.org\/10.3390\/ijms242216515.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5238_CR66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/biomedicines11041071","volume":"11","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, di Meo NA, Rutigliano M, et al. Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice. Biomedicines. 2023;11(4):1071. https:\/\/doi.org\/10.3390\/biomedicines11041071.","journal-title":"Biomedicines"},{"issue":"5","key":"5238_CR67","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.3390\/ijms24054814","volume":"24","author":"G Lucarelli","year":"2023","unstructured":"Lucarelli G, Netti GS, Rutigliano M, et al. MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation. Int J Mol Sci. 2023;24(5):4814. https:\/\/doi.org\/10.3390\/ijms24054814.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5238_CR68","doi-asserted-by":"publisher","first-page":"27034","DOI":"10.1038\/s41598-024-76947-0","volume":"14","author":"MW Helmy","year":"2024","unstructured":"Helmy MW, Youssef MH, Yamari I, et al. Repurposing of sericin combined with dactolisib or vitamin D to combat non-small lung cancer cells through computational and biological investigations. Sci Rep. 2024;14(1):27034. https:\/\/doi.org\/10.1038\/s41598-024-76947-0.","journal-title":"Sci Rep"},{"issue":"3","key":"5238_CR69","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1039\/d0np00041h","volume":"38","author":"W Zhao","year":"2021","unstructured":"Zhao W, Cong Y, Li HM, et al. Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy. Nat Prod Rep. 2021;38(3):470\u201388. https:\/\/doi.org\/10.1039\/d0np00041h.","journal-title":"Nat Prod Rep"},{"issue":"1","key":"5238_CR70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"5238_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"5238_CR72","doi-asserted-by":"publisher","first-page":"bbaa176","DOI":"10.1093\/bib\/bbaa176","volume":"22","author":"FF Hu","year":"2021","unstructured":"Hu FF, Liu CJ, Liu LL, Zhang Q, Guo AY. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform. 2021;22(3):bbaa176. https:\/\/doi.org\/10.1093\/bib\/bbaa176.","journal-title":"Brief Bioinform"},{"issue":"1","key":"5238_CR73","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-024-05186-8","volume":"22","author":"K Zheng","year":"2024","unstructured":"Zheng K, Hai Y, Chen H, Zhang Y, Hu X, Ni K. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med. 2024;22(1):365. https:\/\/doi.org\/10.1186\/s12967-024-05186-8.","journal-title":"J Transl Med"},{"issue":"4","key":"5238_CR74","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s44321-024-00052-y","volume":"16","author":"T Sun","year":"2024","unstructured":"Sun T, Chen J, Yang F, et al. Lipidomics reveals new lipid-based lung adenocarcinoma early diagnosis model. EMBO Mol Med. 2024;16(4):854\u201369. https:\/\/doi.org\/10.1038\/s44321-024-00052-y.","journal-title":"EMBO Mol Med"},{"key":"5238_CR75","doi-asserted-by":"publisher","first-page":"108747","DOI":"10.1016\/j.compbiomed.2024.108747","volume":"178","author":"S Ma","year":"2024","unstructured":"Ma S, Li R, Li G, et al. Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis. Comput Biol Med. 2024;178:108747. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108747.","journal-title":"Comput Biol Med"},{"issue":"12","key":"5238_CR76","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41571-023-00824-4","volume":"20","author":"AM Tsimberidou","year":"2023","unstructured":"Tsimberidou AM, Kahle M, Vo HH, Baysal MA, Johnson A, Meric-Bernstam F. Molecular tumour boards - current and future considerations for precision oncology. Nat Rev Clin Oncol. 2023;20(12):843\u201363. https:\/\/doi.org\/10.1038\/s41571-023-00824-4.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05238-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:02:58Z","timestamp":1786456978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05238-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5238"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05238-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study was conducted using publicly available datasets (TCGA\/GEO), and all data were obtained from databases that have received prior ethical approval. No additional ethical approval or informed consent was required.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1146"}}